The effect of short-term dipyrone administration on cyclosporin pharmacokinetics
暂无分享,去创建一个
[1] B. Rosenkranz,et al. Clinical Pharmacokinetics of Dipyrone and its Metabolites , 1995, Clinical pharmacokinetics.
[2] C. Ponticelli,et al. Controlled trials with cyclosporine in kidney transplantation. , 1994, Transplantation proceedings.
[3] P. Watkins. Noninvasive tests of CYP3A enzymes. , 1994, Pharmacogenetics.
[4] L. Benet,et al. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction , 1992, Clinical pharmacology and therapeutics.
[5] J. Kolars,et al. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. , 1992, The Journal of clinical investigation.
[6] G. Yee,et al. Pharmacokinetic Drug Interactions with Cyclosporin (Part II) , 1990, Clinical pharmacokinetics.
[7] J. Derancourt,et al. Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[8] A. Laupacis,et al. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. , 1984, British journal of clinical pharmacology.
[9] G. Yee,et al. Pharmacokinetic Drug Interactions with Cyclosporin (Part I) , 1990, Clinical pharmacokinetics.